Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001846478-25-000007)

Filing Details

Accession Number:: 0001846478-25-000007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-07 16:09:27
Reporting Period:: 2025-03-05

Filing Date:: 2025-03-07
Accepted Time:: 2025-03-07 16:09:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1023024	Ani Pharmaceuticals Inc	ANIP	Pharmaceutical Preparations (2834)	582301143

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1846478	Ori Gutwerg	C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623	Svp, Generics	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-05	300	$31.49	99,476	No	4	M	Direct
Common Stock	Disposition	2025-03-05	300	$60.03	99,176	No	4	S	Direct
Common Stock	Disposition	2025-03-05	5,084	$60.00	94,092	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2025-03-05	300	$31.49	300	$31.49

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,204		2031-02-15	No	4	M	Direct

Footnotes

The shares were sold in multiple trades at prices ranging from $60.00 to $60.03. The price reported above reflects the weighted average sales price.
25% of the total options vested on each of February 15, 2022, February 15, 2023, February 15, 2024, and February 15, 2025.